Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.24 USD | -0.26% | -5.13% | -10.97% |
May. 16 | Transcript : Syndax Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM | |
May. 15 | Syndax Pharmaceuticals, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2024 * | 31.52M | Sales 2025 * | 108M | Capitalization | 1.64B |
---|---|---|---|---|---|
Net income 2024 * | -307M | Net income 2025 * | -269M | EV / Sales 2024 * | 50.5 x |
Net cash position 2024 * | 44.29M | Net cash position 2025 * | 203M | EV / Sales 2025 * | 13.3 x |
P/E ratio 2024 * |
-5.41
x | P/E ratio 2025 * |
-6.6
x | Employees | 184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.15% |
Latest transcript on Syndax Pharmaceuticals, Inc.
1 day | -0.26% | ||
1 week | -5.13% | ||
Current month | -0.16% | ||
1 month | -12.43% | ||
3 months | -18.85% | ||
6 months | +16.11% | ||
Current year | -10.97% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 15-05-04 |
Peter Ordentlich
FOU | Founder | 55 | 05-10-10 |
Neil Gallagher
PSD | President | 60 | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 17-03-28 |
Dennis Podlesak
CHM | Chairman | 66 | 08-11-30 |
Pierre Legault
BRD | Director/Board Member | 63 | 17-01-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 19.27 | -0.10% | 844,553 |
24-05-30 | 19.29 | -2.18% | 1,993,849 |
24-05-29 | 19.72 | -1.79% | 934,829 |
24-05-28 | 20.08 | -0.99% | 997,728 |
24-05-24 | 20.28 | +0.85% | 821,743 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.97% | 1.64B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- SNDX Stock